Income Statement Tsugami Corporation

Stocks

6101

JP3531800005

Industrial Machinery & Equipment

Market Closed - Japan Exchange 02:30:00 2026-08-13 EDT			5-day change	1st Jan Change
6,230.00 ^JPY	+0.16%		+3.15%	+116.85%

07-30	Tsugami Corporation Provides Earnings Guidance for the Six Months Ending September 30, 2026 and Fiscal Year Ending March 31, 2027	CI
07-30	Tsugami Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2027	CI

a637171.pkzJX159aLdUfj_fa55Q3bAS6Tnpl4dSVV8dUP_5TXY.7iqnbDgyJ44gSHmxDc5lje9dgH-l2cBnOhZ8N56tGEDTD_FvOio7zzEzDw

Published financial data: TSUGAMI CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	93.17B	94.96B	83.93B	107B	129B
Total Revenues	93.17B	94.96B	83.93B	107B	129B
Cost of Goods Sold, Total	64.99B	68.2B	60.26B	71.06B	81.17B
Gross Profit	28.18B	26.76B	23.67B	36.36B	47.97B
Selling General & Admin Expenses, Total	10.22B	8.08B	8.62B	10.26B	10.51B
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	-	2.25B	2.39B	3.14B	2.62B
Depreciation & Amortization - (IS)	-	544M	523M	550M	512M
Other Operating Expenses	-1.99B	84M	207M	254M	138M
Other Operating Expenses, Total	8.23B	10.96B	11.74B	14.2B	13.78B
Operating Income	19.95B	15.8B	11.93B	22.15B	34.2B
Interest Expense, Total	-228M	-259M	-342M	-322M	-333M
Interest And Investment Income	327M	393M	830M	656M	574M
Net Interest Expenses	99M	134M	488M	334M	241M
Income (Loss) On Equity Invest.	-	-1M	-	-	-
Currency Exchange Gains (Loss)	-177M	-424M	240M	84M	-710M
Other Non Operating Income (Expenses)	971M	1.08B	1.07B	1.14B	1.93B
EBT, Excl. Unusual Items	20.84B	16.59B	13.73B	23.71B	35.66B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-16M	-208M	-27M	-5M	-44M
Asset Writedown	-156M	85M	93M	-	-
Other Unusual Items	-1.9B	-	-	-	-
EBT, Incl. Unusual Items	18.78B	16.47B	13.79B	23.71B	35.62B
Income Tax Expense	6.16B	5.62B	5.62B	7.52B	11.3B
Earnings From Continuing Operations	12.62B	10.84B	8.18B	16.18B	24.32B
Net Income to Company	12.62B	10.84B	8.18B	16.18B	24.32B
Minority Interest	-3.13B	-3.15B	-2.8B	-5.28B	-7.57B
Net Income - (IS)	9.49B	7.7B	5.38B	10.9B	16.74B
Net Income to Common Incl Extra Items	9.49B	7.7B	5.38B	10.9B	16.74B
Net Income to Common Excl. Extra Items	9.49B	7.7B	5.38B	10.9B	16.74B
Per Share Items
Net EPS - Basic	191.99	159.39	112.56	231.54	361.19
Basic EPS - Continuing Operations	191.99	159.39	112.56	231.54	361.19
Basic Weighted Average Shares Outstanding	49.41M	48.28M	47.76M	47.08M	46.36M
Net EPS - Diluted	188.07	157.33	111.04	228.55	356.47
Diluted EPS - Continuing Operations	188.07	157.33	111.04	228.55	356.47
Diluted Weighted Average Shares Outstanding	50.44M	48.91M	48.42M	47.7M	46.98M
Normalized Basic EPS	200.21	149.53	120.96	202.6	317.4
Normalized Diluted EPS	196.12	147.59	119.32	199.97	313.24
Dividend Per Share	40	46	48	59	85
Payout Ratio	16.86	27.68	42.97	22.27	19.15
American Depositary Receipts Ratio (ADR)	10	10	10	10	10
Supplemental Items
EBITDA	21.76B	17.84B	13.98B	24.37B	36.38B
EBITA	19.95B	15.8B	11.93B	22.15B	34.2B
EBIT	19.95B	15.8B	11.93B	22.15B	34.2B
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	32.78	34.14	40.71	31.74	31.72
Normalized Net Income	9.89B	7.22B	5.78B	9.54B	14.71B
Non-Cash Pension Expense	595M	773M	850M	954M	1.13B
Supplemental Operating Expense Items
Advertising Expense	-	298M	398M	516M	389M
Selling and Marketing Expenses	-	1.92B	1.72B	2.18B	2.34B
Research And Development Expense From Footnotes	1.9B	2.25B	2.39B	3.14B	2.62B
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	18.84B	25.78B	30.5B	27.73B	42.18B
Total Cash And Short Term Investments	18.84B	25.78B	30.5B	27.73B	42.18B
Accounts Receivable, Total	27.61B	23.12B	27.98B	40.7B	50.32B
Other Receivables	2.4B	2.52B	1.23B	1.26B	872M
Total Receivables	30.01B	25.63B	29.21B	41.95B	51.19B
Inventory	32.62B	38.5B	32.73B	32.63B	32.72B
Prepaid Expenses	234M	198M	178M	157M	194M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	329M	261M	323M	333M	205M
Total Current Assets	82.04B	90.37B	92.94B	103B	126B
Net Property Plant And Equipment	16.11B	16.11B	18.4B	18.54B	20.26B
Long-term Investments	4.4B	4.81B	5.55B	5.18B	6.52B
Other Intangibles, Total	903M	615M	359M	166M	142M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	308M	455M	461M	619M	635M
Other Long-Term Assets, Total	4M	2M	3M	2M	1M
Total Assets	104B	112B	118B	127B	154B
Liabilities
Accounts Payable, Total	22.23B	20.38B	17.55B	17.65B	20.07B
Accrued Expenses, Total	201M	244M	313M	329M	345M
Short-term Borrowings	13.31B	17.7B	16.82B	11.52B	9.01B
Current Portion of Leases	170M	196M	205M	199M	206M
Current Income Taxes Payable	1.85B	1.89B	2.19B	4B	4.32B
Other Current Liabilities	5.1B	3.27B	2.98B	4.62B	7.13B
Total Current Liabilities	42.87B	43.69B	40.05B	38.32B	41.09B
Long-Term Leases	106M	145M	183M	163M	158M
Pension & Other Post Retirement Benefits	924M	918M	903M	967M	931M
Deferred Tax Liability Non Current	1.46B	2.12B	3.56B	3.12B	4.75B
Other Non Current Liabilities	558M	568M	665M	622M	652M
Total Liabilities	45.92B	47.44B	45.35B	43.19B	47.58B
Common Stock, Total	12.34B	12.34B	12.34B	12.34B	12.34B
Additional Paid In Capital	3.22B	3.02B	2.88B	2.88B	706M
Retained Earnings	25.8B	30.94B	34.06B	39.82B	53.4B
Treasury Stock	-2.04B	-2.25B	-3.01B	-861M	-2.77B
Comprehensive Income and Other	6.26B	6.89B	10.32B	8.71B	16.41B
Total Common Equity	45.58B	50.95B	56.6B	62.9B	80.1B
Minority Interest	12.26B	13.97B	15.76B	21.22B	26.37B
Total Equity	57.84B	64.92B	72.36B	84.11B	106B
Total Liabilities And Equity	104B	112B	118B	127B	154B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	48.18M	48.06M	47.44M	47.4M	46.5M
ECS Total Common Shares Outstanding	48.4M	48.18M	47.55M	47.4M	46.59M
Book Value / Share	941.81	1.06K	1.19K	1.33K	1.72K
Tangible Book Value	44.68B	50.34B	56.25B	62.73B	79.96B
Tangible Book Value Per Share	923.15	1.04K	1.18K	1.32K	1.72K
Total Debt	13.59B	18.04B	17.2B	11.89B	9.37B
Net Debt	-5.26B	-7.74B	-13.29B	-15.84B	-32.81B
Debt Equivalent of Unfunded Proj. Benefit Obligation	859M	901M	793M	816M	654M
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	12.26B	13.97B	15.76B	21.22B	26.37B
Equity Method Investments, Total	-	-	-	-	-
Inventories - Raw Materials, Total	12.74B	13.95B	11.43B	10.95B	13.67B
Inventories - Work In Process, Total	6.34B	6.02B	5.44B	5.65B	6.47B
Inventories - Finished Goods, Total	13.54B	18.53B	15.86B	16.03B	12.58B
Inventories - Others	-	1M	1M	1M	2M
Full Time Employees	3.08K	3.1K	3.06K	3.43K	3.52K
Accumulated Allowance for Doubtful Accounts (Supple)	143M	128M	110M	223M	135M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	18.78B	16.47B	13.8B	23.71B	35.62B
Depreciation & Amortization - CF	1.82B	2.04B	2.05B	2.21B	2.18B
Depreciation & Amortization, Total	1.82B	2.04B	2.05B	2.21B	2.18B
(Gain) Loss From Sale Of Asset	172M	123M	-66M	6M	44M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	1M	-	-	-
Other Operating Activities, Total	-3.14B	-4.26B	-3.16B	-4.94B	-8.2B
Change In Accounts Receivable	-4.25B	4.81B	-2.37B	-13.57B	-4.22B
Change In Inventories	-11.5B	-5.88B	7.3B	-530M	2.17B
Change In Accounts Payable	4.49B	-2.11B	-3.76B	605M	236M
Change in Other Net Operating Assets	-64M	-2.89B	-1.9B	1.36B	779M
Cash from Operations	6.3B	8.3B	11.88B	8.86B	28.6B
Capital Expenditure	-2.94B	-1.14B	-2.42B	-2.03B	-1.87B
Sale of Property, Plant, and Equipment	41M	-44M	8M	15M	-191M
Sale (Purchase) of Intangible assets	-109M	-28M	-54M	-72M	-23M
Investment in Marketable and Equity Securities, Total	-1M	-58M	-131M	72M	19M
Other Investing Activities, Total	-5M	-7M	-9M	-9M	-19M
Cash from Investing	-3.01B	-1.28B	-2.6B	-2.02B	-2.08B
Short Term Debt Issued, Total	3.68B	4.51B	-	-	-
Total Debt Issued	3.68B	4.51B	-	-	-
Short Term Debt Repaid, Total	-	-	-917M	-5.25B	-2.45B
Total Debt Repaid	-	-	-917M	-5.25B	-2.45B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-4.32B	-920M	-935M	-968M	-2B
Common Dividends Paid	-1.6B	-2.13B	-2.31B	-2.43B	-3.21B
Common & Preferred Stock Dividends Paid	-1.6B	-2.13B	-2.31B	-2.43B	-3.21B
Other Financing Activities, Total	-1.28B	-1.84B	-2.52B	-115M	-8.27B
Cash from Financing	-3.51B	-379M	-6.69B	-8.76B	-15.93B
Foreign Exchange Rate Adjustments	1.86B	292M	2.12B	-838M	3.86B
Miscellaneous Cash Flow Adjustments	-	-1M	-	-	1M
Net Change in Cash	1.64B	6.93B	4.72B	-2.76B	14.45B
Supplemental Items
Cash Interest Paid	114M	151M	232M	240M	195M
Cash Income Tax Paid (Refund)	6.04B	5.37B	4.27B	6.12B	10.18B
Levered Free Cash Flow	-304M	5.59B	6.2B	4.7B	17.48B
Unlevered Free Cash Flow	-162M	5.75B	6.41B	4.9B	17.69B
Change In Net Working Capital	11.4B	4.99B	618M	9.06B	3.97B
Net Debt Issued / Repaid	3.68B	4.51B	-917M	-5.25B	-2.45B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	13.62	9.14	6.48	11.3	15.19
Return on Total Capital	19.45	12.79	8.64	14.92	20.18
Return On Equity %	24.11	17.67	11.92	20.68	25.52
Return on Common Equity	22.64	15.94	10	18.24	23.42
Margin Analysis
Gross Profit Margin %	30.24	28.18	28.2	33.85	37.15
SG&A Margin	10.97	8.51	10.27	9.55	8.14
EBITDA Margin %	23.36	18.78	16.65	22.69	28.17
EBITA Margin %	21.41	16.64	14.21	20.62	26.48
EBIT Margin %	21.41	16.64	14.21	20.62	26.48
Income From Continuing Operations Margin %	13.54	11.42	9.75	15.07	18.83
Net Income Margin %	10.18	8.1	6.41	10.15	12.97
Net Avail. For Common Margin %	10.18	8.1	6.41	10.15	12.97
Normalized Net Income Margin	10.62	7.6	6.88	8.88	11.39
Levered Free Cash Flow Margin	-0.33	5.88	7.39	4.37	13.54
Unlevered Free Cash Flow Margin	-0.17	6.05	7.64	4.56	13.7
Asset Turnover
Asset Turnover	1.02	0.88	0.73	0.88	0.92
Fixed Assets Turnover	6.38	5.9	4.86	5.82	6.66
Receivables Turnover (Average Receivables)	3.88	3.74	3.29	3.13	2.84
Inventory Turnover (Average Inventory)	2.43	1.92	1.69	2.17	2.48
Short Term Liquidity
Current Ratio	1.91	2.07	2.32	2.68	3.08
Quick Ratio	1.14	1.18	1.49	1.82	2.27
Operating Cash Flow to Current Liabilities	0.15	0.19	0.3	0.23	0.7
Days Sales Outstanding (Average Receivables)	94.1	97.49	111.41	116.68	128.62
Days Outstanding Inventory (Average Inventory)	149.92	190.3	216.32	167.87	146.94
Average Days Payable Outstanding	87.95	104.98	127.39	90.52	84.72
Cash Conversion Cycle (Average Days)	156.07	182.81	200.35	194.03	190.85
Long Term Solvency
Total Debt/Equity	23.49	27.79	23.78	14.13	8.8
Total Debt / Total Capital	19.02	21.74	19.21	12.38	8.09
LT Debt/Equity	0.18	0.22	0.25	0.19	0.15
Long-Term Debt / Total Capital	0.15	0.17	0.2	0.17	0.14
Total Liabilities / Total Assets	44.26	42.22	38.53	33.93	30.88
EBIT / Interest Expense	87.5	61	34.88	68.8	102.69
EBITDA / Interest Expense	95.46	68.87	40.87	75.67	109.24
(EBITDA - Capex) / Interest Expense	82.58	64.46	33.8	69.38	103.63
Total Debt / EBITDA	0.62	1.01	1.23	0.49	0.26
Net Debt / EBITDA	-0.24	-0.43	-0.95	-0.65	-0.9
Total Debt / (EBITDA - Capex)	0.72	1.08	1.49	0.53	0.27
Net Debt / (EBITDA - Capex)	-0.28	-0.46	-1.15	-0.71	-0.95
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	51.1	1.92	-11.62	27.98	20.23
Gross Profit, 1 Yr. Growth %	63.79	-5.04	-11.54	53.59	31.95
EBITDA, 1 Yr. Growth %	106.59	-18.04	-21.63	74.32	49.29
EBITA, 1 Yr. Growth %	120.92	-20.8	-24.5	85.71	54.36
EBIT, 1 Yr. Growth %	120.92	-20.8	-24.5	85.71	54.36
Earnings From Cont. Operations, 1 Yr. Growth %	90.2	-14.07	-24.58	97.86	50.26
Net Income, 1 Yr. Growth %	92.92	-18.88	-30.14	102.77	53.61
Normalized Net Income, 1 Yr. Growth %	135.63	-27.02	-19.98	65.11	54.27
Diluted EPS Before Extra, 1 Yr. Growth %	102.05	-16.34	-29.42	105.83	55.97
Accounts Receivable, 1 Yr. Growth %	35.18	-16.29	21.04	45.44	23.65
Inventory, 1 Yr. Growth %	57.01	18.03	-14.99	-0.31	0.29
Net Property, Plant and Equip., 1 Yr. Growth %	22.85	0.03	14.22	0.74	9.26
Total Assets, 1 Yr. Growth %	30.88	8.29	4.76	8.15	21.01
Tangible Book Value, 1 Yr. Growth %	20.38	12.67	11.74	11.53	27.46
Common Equity, 1 Yr. Growth %	19.23	11.79	11.09	11.12	27.35
Cash From Operations, 1 Yr. Growth %	-7.19	31.83	43.17	-25.48	223
Capital Expenditures, 1 Yr. Growth %	27	-61.12	112.01	-16.25	-7.8
Levered Free Cash Flow, 1 Yr. Growth %	-113.16	-1.94K	10.96	-24.22	272.14
Unlevered Free Cash Flow, 1 Yr. Growth %	-106.7	-3.65K	11.55	-23.61	261.11
Dividend Per Share, 1 Yr. Growth %	53.85	15	4.35	22.92	44.07
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	37.46	24.1	-5.09	6.35	24.04
Gross Profit, 2 Yr. CAGR %	47.48	24.71	-8.35	16.56	42.36
EBITDA, 2 Yr. CAGR %	96.68	30.12	-19.86	16.88	61.32
EBITA, 2 Yr. CAGR %	113.32	32.27	-22.67	18.41	69.31
EBIT, 2 Yr. CAGR %	113.32	32.27	-22.67	18.41	69.31
Earnings From Cont. Operations, 2 Yr. CAGR %	114.38	27.84	-19.5	22.16	72.43
Net Income, 2 Yr. CAGR %	117.73	25.1	-24.72	19.02	76.49
Normalized Net Income, 2 Yr. CAGR %	127.24	31.13	-23.58	14.95	59.6
Diluted EPS Before Extra, 2 Yr. CAGR %	123.2	30.01	-23.16	20.53	79.17
Accounts Receivable, 2 Yr. CAGR %	50.09	6.38	0.66	32.68	34.11
Inventory, 2 Yr. CAGR %	33.35	36.14	0.17	-7.94	-0.01
Net Property, Plant and Equip., 2 Yr. CAGR %	21.72	10.86	6.89	7.27	4.92
Total Assets, 2 Yr. CAGR %	29.51	19.05	6.51	6.44	14.4
Tangible Book Value, 2 Yr. CAGR %	19.68	16.46	12.2	11.63	19.23
Common Equity, 2 Yr. CAGR %	18.46	15.45	11.44	11.1	18.96
Cash From Operations, 2 Yr. CAGR %	-11.25	10.61	37.38	3.29	55.14
Capital Expenditures, 2 Yr. CAGR %	10.77	-29.73	-9.22	33.25	-12.12
Levered Free Cash Flow, 2 Yr. CAGR %	-75.47	55.44	351.32	-8.3	67.93
Unlevered Free Cash Flow, 2 Yr. CAGR %	-82.29	54.27	529.45	-7.69	66.09
Dividend Per Share, 2 Yr. CAGR %	29.1	33.01	9.54	13.25	33.07
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.81	24.42	10.82	4.85	10.79
Gross Profit, 3 Yr. CAGR %	12.15	27.35	11.22	8.86	21.48
EBITDA, 3 Yr. CAGR %	24.54	46.91	9.88	3.84	26.81
EBITA, 3 Yr. CAGR %	24.94	53.32	9.72	3.55	29.35
EBIT, 3 Yr. CAGR %	24.94	53.32	9.72	3.55	29.35
Earnings From Cont. Operations, 3 Yr. CAGR %	16.87	58.06	7.22	8.64	30.89
Net Income, 3 Yr. CAGR %	15.28	56.67	3.02	4.74	29.59
Normalized Net Income, 3 Yr. CAGR %	27.04	55.62	11.23	-1.21	26.79
Diluted EPS Before Extra, 3 Yr. CAGR %	17.74	60.93	6.06	6.71	31.34
Accounts Receivable, 3 Yr. CAGR %	17.21	23.55	11.06	13.8	29.6
Inventory, 3 Yr. CAGR %	13.24	28.04	16.36	0.01	-5.27
Net Property, Plant and Equip., 3 Yr. CAGR %	21.99	14.02	11.97	4.8	7.93
Total Assets, 3 Yr. CAGR %	14.19	22.01	14.08	7.05	11.09
Tangible Book Value, 3 Yr. CAGR %	10.98	17.3	14.87	11.98	16.68
Common Equity, 3 Yr. CAGR %	11.09	16.19	13.98	11.33	16.28
Cash From Operations, 3 Yr. CAGR %	56.49	1.26	20.54	12.04	51.04
Capital Expenditures, 3 Yr. CAGR %	27.83	-21.87	1.53	-11.62	17.86
Levered Free Cash Flow, 3 Yr. CAGR %	-60.15	3.38	38.92	148.99	46.27
Unlevered Free Cash Flow, 3 Yr. CAGR %	-67.47	3.67	38.47	211.65	45.45
Dividend Per Share, 3 Yr. CAGR %	23.96	24.22	22.68	13.83	22.71
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	17.81	10.53	4.15	16.85	15.93
Gross Profit, 5 Yr. CAGR %	23.95	12.95	3.45	22.92	22.76
EBITDA, 5 Yr. CAGR %	39.78	17.54	4.4	34.07	28.13
EBITA, 5 Yr. CAGR %	45.21	17.87	3.12	38.26	30.51
EBIT, 5 Yr. CAGR %	45.21	17.87	3.12	38.26	30.51
Earnings From Cont. Operations, 5 Yr. CAGR %	36.84	18.28	0.68	42.58	29.66
Net Income, 5 Yr. CAGR %	29.25	13.03	-2.79	40.36	27.77
Normalized Net Income, 5 Yr. CAGR %	40.94	15.22	3.67	37.86	28.51
Diluted EPS Before Extra, 5 Yr. CAGR %	35.66	16.93	-0.74	43.36	30.81
Accounts Receivable, 5 Yr. CAGR %	23.01	9.89	10.29	27.12	19.76
Inventory, 5 Yr. CAGR %	15.15	17.26	7.82	12.21	9.51
Net Property, Plant and Equip., 5 Yr. CAGR %	14.47	11.99	15.71	11.27	9.09
Total Assets, 5 Yr. CAGR %	15.66	12.39	11.05	15.53	14.21
Tangible Book Value, 5 Yr. CAGR %	7.71	10.15	11.47	15	16.59
Common Equity, 5 Yr. CAGR %	7.7	9.93	11.23	14.13	15.94
Cash From Operations, 5 Yr. CAGR %	2.55	3.97	48.54	2.07	33.35
Capital Expenditures, 5 Yr. CAGR %	78.49	-1.93	11.48	-3.27	-4.17
Levered Free Cash Flow, 5 Yr. CAGR %	-43.8	2.47	5.2	-1.46	49.87
Unlevered Free Cash Flow, 5 Yr. CAGR %	-50.68	2.73	6.4	-1.03	48.92
Dividend Per Share, 5 Yr. CAGR %	20.11	20.64	17.98	19.71	26.73